Top news from MedWatch this week

Monday
NICE recommends Lundbeck migraine drug
NICE recommends Lundbeck migraine drug
Tuesday
Cochlear partners with Norwegian startup on ”hearing aid” glasses
Almirall expanding in the Nordics – ramps up hiring
Wednesday
Obesity treatment awareness boosts interest in Zealand Pharma’s pipeline
EMA complains about prospect of getting new sex-working neighbors
Thursday
Yearlong losses have almost emptied out Leo Pharma’s coffers
Leo Pharma books multimillion-dollar loss in 2022
Friday
Sandoz fights to keep name secret of CMO behind contaminated antibiotic
The Dicillin scandal grows – two more Danes infected with multiresistant bacteria